A carregar...
Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy
Patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) are prone to present with antibody production deficits associated with recurrent or severe bacterial infections that might benefit from human immunoglobulin (Ig) (IVIg/SCIg) replacement therapy. However, the original IVIg tri...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4993076/ https://ncbi.nlm.nih.gov/pubmed/27597852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00317 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|